Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

Autor: Thorbjørn Krejsgaard, Niels Ødum, Mads Hald Andersen, Veronica Stolearenco, Özcan Met, David L. Petersen, Pieter Spee, Terkild B. Buus, Andreas Willerslev-Olsen, Thomas Litman, Per thor Straten, Tengpeng Hu, Simon Fredholm, Lise Mette Rahbek Gjerdrum, Anders Woetmann, Edda Blümel, Anneline Nansen, Hanne Fogh, Maria Gluud, Robert Gniadecki, Betina Kerstin Lundholt, Claudia Nastasi, Madalena N Monteiro
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Zdroj: Oncotarget
Hu, T, Buus, T B, Krejsgaard, T, Nansen, A, Lundholt, B K, Spee, P, Fredholm, S, Petersen, D L, Blümel, E, Gluud, M, Monteiro, M N, Willerslev-Olsen, A, Andersen, M H, Straten, P T, Met, Ö, Stolearenco, V, Fogh, H, Gniadecki, R, Nastasi, C, Litman, T, Woetmann, A, Gjerdrum, L M R & Ødum, N 2019, ' Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome ', OncoTarget, vol. 10, no. 47, pp. 4894-4906 . https://doi.org/10.18632/oncotarget.27122
ISSN: 1949-2553
DOI: 10.18632/oncotarget.27122
Popis: The voltage-gated potassium channel Kv1.3 (KCNA3) is expressed by a subset of chronically activated memory T cells and plays an important role in their activation and proliferation. Here, we show that primary malignant T cells isolated from patients with Sézary syndrome (SS) express Kv1.3 and are sensitive to potent Kv1.3 inhibitors ShK and Vm24, but not sensitive to a less potent inhibitor [N17A/F32T]-AnTx. Kv1.3 blockade inhibits CD3/CD28-induced proliferation and IL-9 expression by SS cells in a concentration-dependent manner. In parallel, CD3/CD28-mediated CD25 induction is inhibited, whereas Kv1.3 blockade has no effect on apoptosis or cell death as judged by Annexin V and PI staining. In conclusion, we provide the first evidence that malignant T cells in SS express functional Kv1.3 channels and that Kv1.3 blockade inhibits activation-induced proliferation as well as cytokine and cytokine receptor expression in malignant T cells, suggesting that Kv1.3 is a potential target for therapy in SS.
Databáze: OpenAIRE